155 related articles for article (PubMed ID: 38518000)
1. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
Gong X; Gong Y; Wu G; Ke H
Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
4. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
5. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
6. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
8. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
9. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
10. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
Yao ZY; Xing CQ; Zhang T; Liu YW; Xing XL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2235-2244. PubMed ID: 33755961
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
[TBL] [Abstract][Full Text] [Related]
13. High PAQR4 mRNA Expression May Play a Key Role in Prognosis of Kidney Renal Papillary Cell Carcinoma.
Liu C; Cai W; Tang P; Li C
Ann Clin Lab Sci; 2023 Sep; 53(5):701-711. PubMed ID: 37945022
[TBL] [Abstract][Full Text] [Related]
14. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
[No Abstract] [Full Text] [Related]
15. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
Yang L; Ma TJ; Zhang YB; Wang H; An RH
Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
Front Immunol; 2021; 12():657951. PubMed ID: 34531849
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma.
Luo Y; Chen D; Xing XL
Clin Genitourin Cancer; 2023 Oct; 21(5):537-545. PubMed ID: 37455213
[TBL] [Abstract][Full Text] [Related]
19. SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma.
Feng D; Zhang F; Liu L; Xiong Q; Xu H; Wei W; Liu Z; Yang L
Int J Gen Med; 2021; 14():8591-8602. PubMed ID: 34849004
[TBL] [Abstract][Full Text] [Related]
20. Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis.
Yu B; Zhang J; Sun Z; Cao P; Zheng X; Gao Z; Cao H; Zhang F; Wang W
Medicine (Baltimore); 2021 Jan; 100(1):e24257. PubMed ID: 33429832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
